418 related articles for article (PubMed ID: 16169681)
1. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time.
Yamazaki H; Nishiyama K; Tanaka E; Koizumi M; Chatani M
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):77-82. PubMed ID: 16169681
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy for early glottic carcinoma (T1N0M0). The final results of prospective randomized study concerning radiation field.
Chatani M; Matayoski Y; Masaki N; Teshima T; Inoue To
Strahlenther Onkol; 1996 Mar; 172(3):169-72. PubMed ID: 8721266
[TBL] [Abstract][Full Text] [Related]
3. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience.
Reddy SP; Hong RL; Nagda S; Emami B
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1389-94. PubMed ID: 17869013
[TBL] [Abstract][Full Text] [Related]
4. Radiation therapy for early glottic carcinoma: indication for the wedge filter.
Chatani M; Matayoshi Y; Masaki N; Inoue T; Teshima T; Inoue T
Strahlenther Onkol; 1993 Nov; 169(11):655-9. PubMed ID: 8248841
[TBL] [Abstract][Full Text] [Related]
5. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase.
Chatani M; Matayoshi Y; Masaki N; Inoue T
Strahlenther Onkol; 1994 Mar; 170(3):155-61. PubMed ID: 8160096
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
[TBL] [Abstract][Full Text] [Related]
7. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
[TBL] [Abstract][Full Text] [Related]
8. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
[TBL] [Abstract][Full Text] [Related]
9. [Radiation therapy of early glottic cancer (T1N0M0); retrospective review of historical control].
Teshima T; Chatani M; Hata K; Inoue T
Rinsho Hoshasen; 1989 Dec; 34(13):1603-6. PubMed ID: 2622053
[TBL] [Abstract][Full Text] [Related]
10. Overall time in telecobalt therapy for T1 glottic carcinoma treated with 2 Gy per day.
Inoue T; Inoue T; Teshima T; Murayama S; Yamazaki H; Nose T; Tanaka E
Strahlenther Onkol; 1995 Aug; 171(8):475-7. PubMed ID: 7652672
[TBL] [Abstract][Full Text] [Related]
11. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.
Cellai E; Frata P; Magrini SM; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Bonetti B; Vitali E; De Stefani A; Buglione M; Biti G
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1378-86. PubMed ID: 16095847
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.
Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy for larynx carcinoma: long-term results of stage I glottic carcinoma.
Chatani M; Matayoshi Y; Masaki N
Strahlenther Onkol; 1993 Feb; 169(2):102-6. PubMed ID: 8451724
[TBL] [Abstract][Full Text] [Related]
14. Conservative treatment of early glottic carcinomas with exclusive radiotherapy.
Thariat J; Bruchon Y; Bonnetain F; Barillot I; Truc G; Peignaux K; Horiot JC; Maingon P
Cancer Radiother; 2004 Oct; 8(5):288-96. PubMed ID: 15561594
[TBL] [Abstract][Full Text] [Related]
15. Comparative estimation of cure rates for supraglottic and glottic cancer in radiotherapy.
Goleń M; Składowski K; Maciejewski B
Neoplasma; 1999; 46(1):66-71. PubMed ID: 10355537
[TBL] [Abstract][Full Text] [Related]
16. Radiation therapy in early glottic carcinoma: significance of prognostic factors and dose fractionation.
Dinshaw KA; Sharma V
Indian J Cancer; 1990 Sep; 27(3):143-53. PubMed ID: 2090566
[TBL] [Abstract][Full Text] [Related]
17. Duration of symptoms: impact on outcome of radiotherapy in glottic cancer patients.
Hansen O; Larsen S; Bastholt L; Godballe C; Jørgensen KE
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):789-94. PubMed ID: 15708258
[TBL] [Abstract][Full Text] [Related]
18. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
[TBL] [Abstract][Full Text] [Related]
19. Irradiated volume and arytenoid edema after radiotherapy for T1 glottic carcinoma.
Inoue T; Inoue T; Chatani M; Teshima T
Strahlenther Onkol; 1992 Jan; 168(1):23-6. PubMed ID: 1734586
[TBL] [Abstract][Full Text] [Related]
20. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
